Latest Multiple Myeloma Research Foundation Stories
Researchers have discovered why multiple myeloma, a difficult to cure cancer of the bone marrow, frequently recurs after an initially effective treatment that can keep the disease at bay for up to several years.
Cancer Support Community's expanded Cancer Experience Registry created to identify social and emotional needs of people living with multiple myeloma Washington,
Researchers at Moffitt Cancer Center and colleagues have investigated the safety, efficacy and the maximum tolerated dose of pomalidomide for patients with multiple myeloma who have disease relapsed after treatments with other drugs, such as bortezomib and lenalidomide.
Mitchell Vazquez, owner of the GCI Financial, makes noble use of his financial success by donating substantial gifts to Multiple Myeloma Research Foundation.
- An armed gangster.